Table 1 Participants’ characteristics
Eligible Patients (n = 80) | Respondents (n = 64) | Non-respondents (n = 16) | |
|---|---|---|---|
Age | 75 (71–81) | 75 (71–80) | 77 (74–84) |
Male | 42 (52.5%) | 34 (53.1%) | 8 (50%) |
Lives alone | 31 (38.8%) | 25 (39%) | 6 (37.5%) |
COPD | 75 (93.8%) | 60 (93.8%) | 16 (100%) |
Bronchiectasis | 4 (5.0%) | 4 (6.2%) | 0 |
Pulmonary Fibrosis | 1 (1.2%) | 0 | 0 |
Anxiety and/or Depression | 38 (47.5%) | 29 (45.3%) | 9 (56.3%) |
FEV1% predicted | 40 (31–50) | 41 (30–50) | 40 (32–50) |
Forced expiratory ratio (%) | 34 (29–44) | 33 (28–45) | 35 (30–41) |
DLco | 8 (7–10) | 9 (7–11) | 7 (7–9) |
MMRC Dyspnoea Score | 3 (2–4) | 3 (2–4) | 3 (2–4) |
Home Oxygen Use | 45 (56.3%) | 36 (56.3%) | 9 (56.3%) |
Past completion of pulmonary rehabilitation program | 71 (80.7%) | 58 (90.6%) | 13 (81.3%) |
Number of ALDS appointments | 7.5 (4–11) | 8 (4–12) | 6 (4–9) |
Accessed specialist palliative care in ALDS clinic | 66 (82.5%) | 52 (81.3%) | 14 (87.5%) |